Search research articles
Contact Us
Filters
Showing results (121-130 of 154) with videos related to
Page
of 16
Sort By:
American Journal of Hematology
|
June 24, 2015
Early cytotoxic lymphocyte expansion contributes to a deep molecular response to dasatinib in patients with newly diagnosed chronic myeloid leukemia in the chronic phase: results of the D-first study
Noriyoshi Iriyama, Shin Fujisawa, Chikashi Yoshida, et al.
Oncology Reports
|
September 27, 2016
Association of pleural effusion with an early molecular response in patients with newly diagnosed chronic-phase chronic myeloid leukemia receiving dasatinib: Results of a D-First study
Maki Hagihara, Noriyoshi Iriyama, Chikashi Yoshida, et al.
Leukemia & Lymphoma
|
June 9, 2016
Hyper-recovery of platelets after induction therapy is a predictor of relapse-free survival in acute myeloid leukemia
Etsuko Yamazaki, Heiwa Kanamori, Megumi Itabashi, et al.
Blood
|
October 27, 2012
Treatment of relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: the Nagasaki Transplant Group experience
Hidehiro Itonaga, Hideki Tsushima, Jun Taguchi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 8, 2018
Efficacy and Long-Term Outcomes of Autologous Stem Cell Transplantation in POEMS Syndrome: A Nationwide Survey in Japan
Chika Kawajiri-Manako, Emiko Sakaida, Chikako Ohwada, et al.
Hematological Oncology
|
January 11, 2020
Treatment with mogamulizumab or lenalidomide for relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: The Nagasaki transplant group experience
Hikaru Sakamoto, Hidehiro Itonaga, Yasushi Sawayama, et al.
Blood
|
November 26, 2010
A Markov decision analysis of allogeneic hematopoietic cell transplantation versus chemotherapy in patients with acute myeloid leukemia in first remission
Saiko Kurosawa, Takuhiro Yamaguchi, Shuichi Miyawaki, et al.
Leukemia Research
|
February 7, 2018
Regulatory T cell inhibition by dasatinib is associated with natural killer cell differentiation and a favorable molecular response-The final results of the D-first study
Yuho Najima, Chikashi Yoshida, Noriyoshi Iriyama, et al.
Radiation Oncology Journal
|
March 29, 2024
Impact of adaptive radiotherapy on survival in locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiotherapy
Yusuke Uchinami, Koichi Yasuda, Hideki Minatogawa, et al.
Hematological Oncology
|
September 2, 2018
The outcome and characteristics of patients with relapsed adult T cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation
Koji Kato, Naokuni Uike, Atsushi Wake, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 154) with videos related to
Sort By:
Page
of 16
American Journal of Hematology
|
June 24, 2015
Early cytotoxic lymphocyte expansion contributes to a deep molecular response to dasatinib in patients with newly diagnosed chronic myeloid leukemia in the chronic phase: results of the D-first study
Noriyoshi Iriyama, Shin Fujisawa, Chikashi Yoshida, et al.
Oncology Reports
|
September 27, 2016
Association of pleural effusion with an early molecular response in patients with newly diagnosed chronic-phase chronic myeloid leukemia receiving dasatinib: Results of a D-First study
Maki Hagihara, Noriyoshi Iriyama, Chikashi Yoshida, et al.
Leukemia & Lymphoma
|
June 9, 2016
Hyper-recovery of platelets after induction therapy is a predictor of relapse-free survival in acute myeloid leukemia
Etsuko Yamazaki, Heiwa Kanamori, Megumi Itabashi, et al.
Blood
|
October 27, 2012
Treatment of relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: the Nagasaki Transplant Group experience
Hidehiro Itonaga, Hideki Tsushima, Jun Taguchi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 8, 2018
Efficacy and Long-Term Outcomes of Autologous Stem Cell Transplantation in POEMS Syndrome: A Nationwide Survey in Japan
Chika Kawajiri-Manako, Emiko Sakaida, Chikako Ohwada, et al.
Hematological Oncology
|
January 11, 2020
Treatment with mogamulizumab or lenalidomide for relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: The Nagasaki transplant group experience
Hikaru Sakamoto, Hidehiro Itonaga, Yasushi Sawayama, et al.
Blood
|
November 26, 2010
A Markov decision analysis of allogeneic hematopoietic cell transplantation versus chemotherapy in patients with acute myeloid leukemia in first remission
Saiko Kurosawa, Takuhiro Yamaguchi, Shuichi Miyawaki, et al.
Leukemia Research
|
February 7, 2018
Regulatory T cell inhibition by dasatinib is associated with natural killer cell differentiation and a favorable molecular response-The final results of the D-first study
Yuho Najima, Chikashi Yoshida, Noriyoshi Iriyama, et al.
Radiation Oncology Journal
|
March 29, 2024
Impact of adaptive radiotherapy on survival in locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiotherapy
Yusuke Uchinami, Koichi Yasuda, Hideki Minatogawa, et al.
Hematological Oncology
|
September 2, 2018
The outcome and characteristics of patients with relapsed adult T cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation
Koji Kato, Naokuni Uike, Atsushi Wake, et al.
Page
of 16